Pharmacogenetics of antidepressants – A step to individualized therapy
INTRODUCTION
Depressive disorders are among the most common diseases today, with more than 350 million patients and an annual prevalence of 4.7% globally [1,2]. They are the most common mental disorders in the general population, with an incidence twice as high among women as among men....
